MYQORZO

Serial Number 97619234
734

Registration Progress

Application Filed
Oct 4, 2022
Under Examination
Mar 21, 2023
Approved for Publication
Jan 24, 2023
Published for Opposition
Jan 24, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Mar 21, 2026 66 days
Statement of Use required (all extensions used)

Trademark Image

MYQORZO

Basic Information

Serial Number
97619234
Filing Date
October 4, 2022
Published for Opposition
January 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Jan 5, 2026
Application
Pending
Classes
005

Rights Holder

Cytokinetics, Incorporated

03
Address
350 Oyster Point Blvd
South San Francisco, CA 94080

Ownership History

Cytokinetics, Incorporated

Original Applicant
03
South San Francisco, CA

Cytokinetics, Incorporated

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
B. Brett Heavner

USPTO Deadlines

Next Deadline
66 days remaining
NOA E-Mailed - SOU Required
Due Date
March 21, 2026

Application History

29 events
Date Code Type Description Documents
Jan 5, 2026 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 5, 2026 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 17, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 31, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 18, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 10, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 13, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 15, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 15, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 8, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 8, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 21, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 17, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 17, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 7, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction

Classification

International Classes
005